Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | 3 | 5 | 4 | 1 | 12 |
Wet macular degeneration | D057135 | EFO_0004683 | — | — | — | 1 | 2 | — | 3 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | — | 1 | 2 | 3 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | — | 1 | 2 | 3 |
Sclerosis | D012598 | — | — | — | — | — | 1 | 2 | 3 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | 1 | 1 | 2 |
Polypoidal choroidal vasculopathy | D000092342 | — | — | — | — | — | 1 | — | 1 |
Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | — | 1 | — | 1 |
Immunosuppression therapy | D007165 | — | — | — | — | — | 1 | — | 1 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Choroidal neovascularization | D020256 | — | — | — | 1 | 3 | — | 2 | 5 |
Macular edema | D008269 | — | — | — | — | 2 | — | 2 | 4 |
Retinal diseases | D012164 | — | H35.9 | — | — | 1 | — | — | 1 |
Eye diseases | D005128 | EFO_0003966 | H44 | — | — | 1 | — | — | 1 |
Retinal neovascularization | D015861 | — | H35.05 | — | — | 1 | — | — | 1 |
Degenerative myopia | D047728 | — | H44.2 | — | — | 1 | — | — | 1 |
Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Retinal detachment | D012163 | EFO_0005773 | H33.2 | — | 1 | — | — | — | 1 |
Uveitis | D014605 | EFO_1001231 | H20.9 | — | 1 | — | — | — | 1 |
Ornithine carbamoyltransferase deficiency disease | D020163 | EFO_0007409 | E72.4 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pathologic neovascularization | D009389 | — | — | — | — | — | — | 2 | 2 |
Myopia | D009216 | EFO_0003927 | H52.1 | — | — | — | — | 1 | 1 |
Vision disorders | D014786 | — | H53.11 | — | — | — | — | 1 | 1 |
Low vision | D015354 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Maxacalcitol |
INN | maxacalcitol |
Description | Maxacalcitol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target vitamin D3 receptor. |
Classification | Small molecule |
Drug class | vitamin D analogs |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O |
PDB | — |
CAS-ID | 103909-75-7 |
RxCUI | — |
ChEMBL ID | CHEMBL333950 |
ChEBI ID | — |
PubChem CID | 12019456 |
DrugBank | DB06272 |
UNII ID | N2UJM5NBF6 (ChemIDplus, GSRS) |